JUVISY-SUR-ORGE, France

Cyrille Pauthenier

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Les Laboratoires Servier, Abolis Biotechnologies. Active years: 2024-2026.

USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Cyrille Pauthenier: Innovator in Biosynthesis

Introduction

Cyrille Pauthenier is a notable inventor based in Juvisy-sur-Orge, France. He has made significant contributions to the field of biotechnology, particularly in the biosynthesis of flavonoids. With a total of 3 patents, his work focuses on the development of recombinant microorganisms for the production of valuable compounds.

Latest Patents

Cyrille Pauthenier's latest patents include a method for biosynthesizing diosmetin and/or hesperetin in a microorganism. This invention relates to a recombinant microorganism that is modified to produce diosmetin and/or hesperetin, along with its applications in producing these compounds. Another significant patent is for the biosynthesis of diosmin and/or hesperidin in a microorganism, which also involves a recombinant microorganism capable of producing these beneficial compounds.

Career Highlights

Throughout his career, Cyrille has worked with prominent companies in the biotechnology sector, including Abolis Biotechnologies and Les Laboratoires Servier. His experience in these organizations has allowed him to advance his research and contribute to innovative solutions in the field.

Collaborations

Cyrille Pauthenier has collaborated with notable professionals in his field, including Célia Roussel and André Le Jeune. These collaborations have further enriched his research and development efforts.

Conclusion

Cyrille Pauthenier is a distinguished inventor whose work in biosynthesis has the potential to impact various industries. His innovative patents and collaborations highlight his commitment to advancing biotechnology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…